Impact of mepolizumab on patient-reported outcomes in eosinophilic granulomatosis with polyangiitis by using ANCA-associated vasculitis patient-reported outcomes (AAV-PRO) questionnaire: the faster the better?
Sara Monti and Paolo Delvino, University of Pavia, Italy
To assess the effect of mepolizumab on patient-reported outcomes in patients with refractory ENT manifestations and/or asthma secondary to EGPA by using the AAV PRO questionnaire.
Sequential treatment with Rituximab and Mepolizumab for the induction and maintenance of remission in patients with EGPA: a retrospective study
Giacomo Emmi and Augusto Vaglio, University of Firenze, Italy
To investigate retrospectively the efficacy and safety of a sequential therapeutic regimen based on Rituximab induction and MEPO maintenance in EGPA patients with systemic disease manifestations.